
Sign up to save your podcasts
Or
Ketamine has gone from a recreational psychedelic to an approved treatment, and it has caught on in Silicon Valley in a big way. Are the long-term effects of using ketamine—recreationally or therapeutically—sufficiently known? Are we witnessing them right now?
Guest: Shayla Love, staff writer for the Atlantic.
Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.
Learn more about your ad choices. Visit megaphone.fm/adchoices
4.5
5353 ratings
Ketamine has gone from a recreational psychedelic to an approved treatment, and it has caught on in Silicon Valley in a big way. Are the long-term effects of using ketamine—recreationally or therapeutically—sufficiently known? Are we witnessing them right now?
Guest: Shayla Love, staff writer for the Atlantic.
Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.
Learn more about your ad choices. Visit megaphone.fm/adchoices
8,502 Listeners
38,025 Listeners
1,868 Listeners
988 Listeners
6,274 Listeners
2,854 Listeners
1,018 Listeners
7,744 Listeners
1,005 Listeners
3,456 Listeners
1,943 Listeners
1,378 Listeners
5,653 Listeners
14,491 Listeners
86,360 Listeners
24,526 Listeners
111,590 Listeners
8,758 Listeners
2,020 Listeners
240 Listeners
23,939 Listeners
10,058 Listeners
2,382 Listeners
1,285 Listeners
1,189 Listeners
5,445 Listeners
410 Listeners
15,225 Listeners
59 Listeners
46 Listeners
94 Listeners
10 Listeners
5 Listeners